Dr. Reddy's Laboratories Ltd.

₹1244.7

Dr. Reddy's Laboratories Ltd.

Add Alert
Add Watchlist

₹1244.7

₹1244.7

21.0 (1.72%) - 2 Oct 2025 04:26 PM

About Company

Dr. Reddy’s Laboratories is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations. The company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. 

Market Cap. ₹ 103,884 Cr.
52 Week - High/Low ₹ 1,421/1,020
P/E Ratio 15.07
P/B Ratio 3.60
Enterprise Value ₹ 103,690 Cr.
ROE % 20.25
RSI Value 41.58
EMA 50 1271.06
EMA 200 1252.83
Market Cap. ₹ 103,884 Cr.
52 Week - High/Low ₹ 1,421/1,020
P/E Ratio 18.28
P/B Ratio 3.10
Enterprise Value ₹ 102,057 Cr.
ROE % 18.61
RSI Value 41.58
EMA 50 1271.06
EMA 200 1252.83

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.